Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and G...
Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding
About this item
Full title
Author / Creator
Iyer, Vivek N. , Apala, Dinesh R. , Pannu, Bibek S. , Kotecha, Aditya , Brinjikji, Waleed , Leise, Michael D. , Kamath, Patrick S. , Misra, Sanjay , Begna, Kebede H. , Cartin-Ceba, Rodrigo , DuBrock, Hilary M. , Krowka, Michael J. , O'Brien, Erin K. , Pruthi, Rajiv K. , Schroeder, Darrell R. and Swanson, Karen L.
Publisher
England: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
To present a multiyear clinical experience with intravenous bevacizumab for the management of severe gastrointestinal bleeding and/or epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
All patients treated with intravenous bevacizumab for severe hereditary hemorrhagic telangiectasia–related bleeding from June 1, 2013, throug...
Alternative Titles
Full title
Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1993993984
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1993993984
Other Identifiers
ISSN
0025-6196
E-ISSN
1942-5546
DOI
10.1016/j.mayocp.2017.11.013
